GGrantIndex
← Leaderboards

Bruce Jenkins

Massachusetts General Hospital

$9,865,800
Attributed
$15,130,664
Total exposure
8
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.8M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,130,664 · 8

By mechanism

R01$7,780,456 · 3
RF1$5,168,060 · 2
S10$2,000,000 · 1
P01$161,817 · 1
P41$20,331 · 1

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposMagnetic Resonance ImagingMetabolicMeasurementBrain RegionDopamine ReceptorHemodynamicsImageAmphetaminesMicrodialysisAnimalsStimulusPredispositionFunctional Magnetic Resonance ImagingBrainSynapsesS DiseaseBaseNeuroinflammationPositron-Emission TomographyMagnetic Resonance SpectroscopyMouse ModelBehavior TestCocaine

Grant awards (23)

Metabolomic characterization of normal aging and Alzheimer's disease under anesthesia- surgery stimuli$770,955
R01 · FY2025 · AG · contact PI
Metabolomic characterization of normal aging and Alzheimer's disease under anesthesia- surgery stimuli$786,689
R01 · FY2024 · AG · contact PI
Protective roles of taurine in Alzheimer's disease brain$657,269
R01 · FY2024 · AG · contact PI
Metabolomic characterization of normal aging and Alzheimer's disease under anesthesia- surgery stimuli$786,689
R01 · FY2023 · AG
Metabolomic characterization of normal aging and Alzheimer's disease under anesthesia- surgery stimuli$786,689
R01 · FY2022 · AG
Metabolomic characterization of normal aging and Alzheimer's disease under anesthesia- surgery stimuli$786,689
R01 · FY2021 · AG
Protective roles of taurine in Alzheimer's disease brain$2,337,294
RF1 · FY2020 · AG · contact PI
Sphingosine-1-phosphate induced modulation of inflammation in aging and Alzheimer's disease$2,830,766
RF1 · FY2017 · AG
Imaging Dopamine Mediated Neurovascular Coupling$376,877
R01 · FY2010 · DA · contact PI
Imaging Dopamine Mediated Neurovascular Coupling$377,376
R01 · FY2009 · DA · contact PI
Imaging Dopamine Mediated Neurovascular Coupling$377,376
R01 · FY2008 · DA · contact PI
Combined MRI/PET Imager for Simultaneous Acquisition of PET/MRI Data$2,000,000
S10 · FY2007 · RR · contact PI
Imaging Dopamine Mediated Neurovascular Coupling$364,828
R01 · FY2007 · DA · contact PI
Imaging Dopamine-Mediated Neuro-Vascular Coupling$431,361
R01 · FY2005 · DA
Imaging Dopamine-Mediated Neuro-Vascular Coupling$431,361
R01 · FY2004 · DA
Imaging Dopamine-Mediated Neuro-Vascular Coupling$431,361
R01 · FY2003 · DA
Imaging Dopamine-Mediated Neuro-Vascular Coupling$414,936
R01 · FY2002 · DA
Synaptic Mechanisms of Dopaminergically Mediated MRI Signal Changes$0
P01 · FY2002 · DA
NMR STUDIES OF TRANSGENIC MOUSE MODELS OF HUNTINGTONS DISEASE &ALS$0
P41 · FY2002 · RR
NMR STUDIES OF TRANSGENIC MOUSE MODELS OF HUNTINGTONS DISEASE &ALS$0
P41 · FY2001 · RR
Synaptic Mechanisms of Dopaminergically Mediated MRI Signal Changes$0
P01 · FY2001 · DA
Synaptic Mechanisms of Dopaminergically Mediated MRI Signal Changes$161,817
P01 · FY2000 · DA
NMR STUDIES OF TRANSGENIC MOUSE MODELS OF HUNTINGTONS DISEASE &ALS$20,331
P41 · FY2000 · RR